In This Section
News Archive

Black Triangle Removal

The Medicines and Healthcare products Regulatory Agency (MHRA) has reviewed the benefits and risks associated with Circadin and has confirmed that from Friday 3rd August 2012, there will no longer be a requirement for this product to show a black triangle on its packaging.

Circadin was first approved in the EU in June 2007 and has since gained approval in a further 16 countries world-wide, with approval pending in a further 10 countries. To date Circadin is estimated to have a world-wide total of 307,600 patient years of experience. 

 

Call us on
+44 (0)1438 727 822
Email Us
office2@flynnpharma.com
Enquire Online
Thank you for letting us use cookies to improve your experience. For more information on the cookies we use see our privacy policy.